Drug Shortage Report for LUPIN-CEPHALEXIN
| Report ID | 216518 |
| Drug Identification Number | 02469170 |
| Brand name | LUPIN-CEPHALEXIN |
| Common or Proper name | LUPIN-CEPHALEXIN |
| Company Name | LUPIN PHARMA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | CEPHALEXIN |
| Strength(s) | 125MG |
| Dosage form(s) | POWDER FOR SUSPENSION |
| Route of administration | ORAL ORAL |
| Packaging size | 100mL and 150mL |
| ATC code | J01DB |
| ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2024-01-18 |
| Estimated end date | 2024-04-01 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-01-18 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 550-1111 RUE ST-CHARLES OUEST LONGUEUIL, QUEBEC CANADA J4K 5G4 |
| Company contact information | lupin@lsu3pl.ca (Customer service / Service à la clientèle) |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2024-01-18 | French | Compare |
| v1 | 2024-01-18 | English | Compare |
Showing 1 to 2 of 2